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A multidisciplinary panel debated the role of screening mammography in fighting breast can-
cer during the Health and Medicine for Women continuing medical education (CME†) con-
ference at Yale Medical School in September 2010. Different guidelines from professional
societies have presented conflicting recommendations for patients regarding both the ben-
efits of mammography and the appropriate age and frequency of screening. In addition, a
recent longitudinal study argues that screening mammography may only offer a modest
benefit in terms of reducing cancer mortality. In light of these considerations, the panel de-
bated whether mammography should be an informed decision that must be discussed and
individualized for each patient based on the context of risk factors such as family history,
age, and genetic dispositions.
Arguments  about  mammography  are
not going to go away, said Dr. Ronald Lan-
nin, Professor of Surgery and Director of the
Yale-New Haven Breast Center, in response
to questions regarding the efficacy of mam-
mography as a screening tool for breast can-
cer during a panel discussion at Yale Medical
School’s Health and Medicine for Women
conference in September 2010.
The role of screening mammography
in fighting cancer has been a focus of spe-
cial attention and debate during the past
year, as different guidelines from profes-
sional societies have presented conflicting
recommendations  for  patients  regarding
both the benefits of mammography and the
appropriate age and frequency with which
to get screened. 
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care, routine screening, false-positiveWhen  the  U.S.  Preventive  Services
Task Force (USPSTF) [1] released a new
statement in November 2009 recommend-
ing  against  the  use  of  routine  screening
mammography in women aged 40 to 49, it
raised a groundswell of rejection nation-
wide both from providers in the medical
community and patients. The statement also
recommended that women between the ages
of 50 and 74 have mammograms less fre-
quently  —  every  two  years,  rather  than
every  year.  The  recommendations  were
confusing for many as they went against
longstanding  guidelines,  including  those
from the American Cancer Society [2], en-
couraging women to have yearly mammo-
grams  starting  at  age  40.  However,  as
claimed by the USPSTF, the revised guide-
lines aimed to reduce potential harm asso-
ciated  with  over-treatment  and
false-positive  results  of  mammograms.
Those include psychological stress, unnec-
essary imaging tests and biopsies in women
without cancer, or over-diagnosis of lesions
that would not shorten a woman’s life even
if they were to become clinically apparent. 
Further adding to this controversy is a
recent study by Kalager et al. [3], “Effect of
Screening Mammography on Breast Cancer
Mortality in Norway,” published in the Sep-
tember 2010 issue of the New England Jour-
nal of Medicine (NEJM). The study looked
at what occurred in Norway before and after
1996, when the country began to implement
its Breast Cancer Screening Program, offer-
ing mammograms to all women between the
ages of 50 and 69. Simultaneously, the coun-
try organized multidisciplinary breast can-
cer  teams  composed  of  radiologists,
pathologists,  surgeons,  oncologists,  and
nurses to treat women with breast cancer re-
gardless of age. The study analyzed 40,075
women with breast cancer and found a 10
percent  reduction  in  mortality  among
women who received both screening mam-
mography and modern cancer treatment. Yet
to the investigator’s surprise, the group that
was not eligible for screening mammogra-
phy due to their age still had a significant
mortality reduction of 8 percent — a reduc-
tion that reflected the establishment of mod-
ern multidisciplinary treatments rather than
screening mammograms. The reduction re-
flected the establishment of modern multi-
disciplinary treatments rather than screening
mammograms. What this means, according
to Dr. H. Gilbert Welch in an accompanying
editorial [4] to the study, is that “the relative
reduction  in  mortality  due  to  screening
mammography alone could be as low as 2
percent.” Overall, the study concluded that
screening mammography reduces the rate of
death from breast cancer, although the per-
centage of its benefits is modest. 
“The bottom line is that there is a ben-
efit to mammography, but it’s pretty small,”
Dr. Lannin said during the panel discussion
at the Yale conference. “I think the general
assumption of the benefit of mammography
is overrated. It’s only about 10 percent of the
time where the cancer found on a mammo-
gram really makes a difference as opposed
to waiting until you find it on the physical
exam. In 20 percent of the cases, the cancer
is already incurable by the time it’s found on
the mammogram. In another 20 percent, the
mammogram diagnoses a cancer that is ir-
relevant or one that would have never both-
ered the patient in the rest of her lifetime.” 
Other members of the panel included
Dr.  Erin  Hofstatter,  who  recently  joined
Yale’s Division of Breast Oncology as an
Assistant Professor in Medical Oncology;
Ellen Matloff, MS, Director of Cancer Ge-
netic Counseling at Yale Cancer Center; and
Dr. Lubina Pal, Director of the Programs for
Reproductive Aging and Bone Health and
Polycystic Ovary Syndrome in Yale’s Re-
productive Endocrinology Department. 
As far as the panel’s current screening
recommendation for practice at Yale, Dr.
Lannin’s recommendation is to follow what
most other agencies are comfortable with:
“Start at age 40 and go from there.” 
Dr. Hofstatter agrees: “I would start an-
nually at age at 40. Granted, I am biased be-
cause I see women who are 40, and their
cancer got picked up on mammogram.” 
By highlighting the modest benefits of
mammography, Kalager et al. remind ob-
servers in the medical community and the
general public that the decision to undergo
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Welch put it in the NEJM editorial, it’s a
“delicate balance between modest benefit
and modest harm.” It should be an informed
decision that must be discussed and individ-
ualized for each patient based on the context
of risk factors such as family history, age,
and genetic dispositions. 
“The bottom line is that the mammogra-
phy is not perfect, but it’s what we have right
now,” Matloff said. “We need more data.
What we may see 10 years from now is that
everyone in the population will have genetic
studies, and based on your genetic screen,
some will start mammogram at 25, some at
40, and others may not need it until 55. 
“But we are not there yet.”
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